D. van der Heijde
- Rheumatology top 0.5%
- Immunology top 5%
- Hematology top 2%
- Surgery
- Pharmacology top 10%
- Co-authors
- Joachim SieperJürgen BraunPhilippe RavaudMaxime DougadosG H KingsleyWalter P. MaksymowychS. PaternotteRubén Burgos‐Vargas
- Topics
- Rheumatoid Arthritis Research and Therapies (49 papers)Spondyloarthritis Studies and Treatments (41 papers)Psoriasis: Treatment and Pathogenesis (13 papers)
- Cited by
- RheumatologyHematologyImmunology
- Partner nations
- NetherlandsUnited StatesCanada
In The Last Decade
D. van der Heijde
69 papers receiving 1.6k citations
Hit Papers
Peers
Comparison fields: 5 of 90
- Rheumatology 1.3k
- Immunology 492
- Hematology 415
- Surgery 193
- Pharmacology 152
Countries citing papers authored by D. van der Heijde
This map shows the geographic impact of D. van der Heijde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. van der Heijde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. van der Heijde more than expected).
Fields of papers citing papers by D. van der Heijde
This network shows the impact of papers produced by D. van der Heijde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. van der Heijde. The network helps show where D. van der Heijde may publish in the future.
Co-authorship network of co-authors of D. van der Heijde
This figure shows the co-authorship network connecting the top 25 collaborators of D. van der Heijde. A scholar is included among the top collaborators of D. van der Heijde based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. van der Heijde. D. van der Heijde is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | Tofacitinib Treatment in Patients with Psoriatic Arthritis and Rates of Radiologic Progression According to Baseline CRP Levels : Results from a Phase 3 Clinical Study | 1 |
| 3 | Assessment of Radiographic Progression in Patients with Rheumatoid Arthritis Treated with Tofacitinib: Data from an Open-Label Long-Term Extension Study over 3 Years | 3 |
| 4 | LONG-TERM EFFICACY AND TOLERABILITY OF GOLIMUMAB IN ACTIVE NONRADIOGRAPHIC AXIAL SPONDYLOARTHRITIS : RESULTS OF THE OPEN-LABEL EXTENSION OF A RANDOMIZED, DOUBLE-BLIND STUDY | 1 |
| 5 | Sociodemographic and Health Status Characteristics Explain Five Clinical Outcome and Radiographic Trajectories in Early Rheumatoid Arthritis: Data from the CATCH Cohort | 1 |
| 6 | Is It Worth to Include MRI of the Spine in the ASAS Classification Criteria for Axial Spondyloarthritis | 0 |
| 7 | EVALUATION OF REFERRAL MODELS FOR AXIAL SPONDYLOARTHRITIS IN PRIMARY CARE IN THE SPONDYLOARTHRITIS CAUGHT EARLY COHORT | 1 |
| 8 | Improvement in Signs and Symptoms of Active Ankylosing Spondylitis Following Treatment with Anti-Interleukin (IL)-17A Monoclonal Antibody Secukinumab Are Paralleled by Reductions in Acute Phase Markers and Inflammatory Markers S100A8 and A9 (Calgranulin A and B) | 2 |
| 9 | Long Term Inhibition of Interleukin (IL)-17A with Secukinumab Improves Clinical Symptoms and Reduces Spinal Inflammation As Assessed by Magnetic Resonance Imaging in Patients with Ankylosing Spondylitis. | 4 |
| 10 | 8 | |
| 11 | Interleukin-17A Blockade with Secukinumab Reduces Spinal Inflammation in Patients with Ankylosing Spondylitis As Early As Week 6, As Detected by Magnetic Resonance Imaging | 12 |
| 12 | 70 | |
| 13 | 183 | |
| 14 | 14 | |
| 15 | 145 | |
| 16 | 41 | |
| 17 | Ankylosing spondylitis and the risk of fracture. | 1 |
| 18 | Evaluation of clinically relevant changes and states in symptomatic outcome variables in osteoarthritis | 5 |
| 19 | 28 | |
| 20 | On the difficulties of establishing a consensus on the definition of and diagnostic investigations for reactive arthritis. Results and discussion of a questionnaire prepared for the 4th International Workshop on Reactive Arthritis, Berlin, Germany, July 3-6, 1999. | 123 |
About D. van der Heijde
D. van der Heijde is a scholar working on Rheumatology, Immunology and Pathology and Forensic Medicine, having authored 72 papers that have together received 1.6k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (49 papers), Spondyloarthritis Studies and Treatments (41 papers) and Psoriasis: Treatment and Pathogenesis (13 papers). The work is most often cited by research in Rheumatology (1.3k citations), Hematology (415 citations) and Immunology (492 citations). D. van der Heijde has collaborated with scholars based in Netherlands, United States and Canada. Frequent co-authors include Joachim Sieper, Jürgen Braun, Philippe Ravaud, Maxime Dougados, G H Kingsley, Jürgen Braun, Walter P. Maksymowych, S. Paternotte, Rubén Burgos‐Vargas and Claire Bombardier. Their work appears in journals such as Annals of the Rheumatic Diseases, Osteoarthritis and Cartilage and Lara D. Veeken.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.